Thread Rating:

billryan
billryan
Joined: Nov 2, 2009
  • Threads: 192
  • Posts: 11746
Thanks for this post from:
Mission146
August 5th, 2021 at 9:18:34 PM permalink
Quote: darkoz

That makes no sense, really.

They have real trials?

With drug regulatory agencies overlooking the results?

You just have a problem when the trial doesn't pass stringent regulatory processes? You feel that the company was lying? You feel success should have been guaranteed by the company?

And what do you mean "CNN, according to you, reported"? I supplied a link to the article so for you to word it like that makes it sound like I am lying.



This is the article you linked. I don't speak Portuguese. Do you?


A farmacêutica Biomm informou nesta segunda-feira (2) que recebeu autorização da Agência Nacional de Vigilância Sanitária (Anvisa) para iniciar o estudo clínico de fase 3 do anticorpo monoclonal leronlimabe no Brasil contra a covid-19.

De acordo com o CEO da companhia, Heraldo Marchezini, os testes ajudam a esclarecer as informações necessárias para encontrar uma nova alternativa no tratamento da covid-19 em pacientes internados.

ADVERTISING

Leia mais
Covid-19: EUA autorizam uso emergencial de tratamento com anticorpo monoclonal
Anvisa aprova uso emergencial de novo coquetel de anticorpos contra Covid-19
Anvisa tem 90 medicamentos em lista de ensaio clínico para tratamento da Covid
A investigação será realizada em 35 centros de pesquisa com 612 pacientes que se encontram hospitalizados e com necessidade de suporte para oxigenação. O objetivo do medicamento, segundo a farmacêutica, é impedir que a doença evolua para um caso mais grave, com necessidade de ventilação mecânica invasiva.

O leronlimab age para prevenir uma resposta excessiva do sistema imunológico de pacientes infectados com o novo coronavírus, reduzindo a superprodução de citocinas inflamatórias, também conhecidas como "tempestade de citocinas". "Esta tempestade inflamatória, que agrava a condição clínica significativamente, pode, muitas vezes, levar o paciente a óbito", declara a Biomm.

O ensaio clínico será conduzido pela Academic Research Organization (ARO) do Hospital Israelita Albert Einstein (HIAE), em colaboração com a CytoDyn, empresa americana responsável pelo desenvolvimento do medicamento, e a Biomm, parceira exclusiva para a comercialização do leronlimab no Brasil.



Tópicos

Covid-19
MAIS LIDAS NA CNN
1
STJ concede habeas corpus e solta suspeito de atear fogo ao Borba Gato
2
Presidente Bolsonaro só vira réu se denúncia passar pela Câmara, diz professor
3
Veja como votaram os deputados na comissão do voto impresso
4
PEC do Voto Impresso vai para votação em comissão: entenda mudanças propostas
5
Tandara é suspensa por potencial violação antidoping e está fora das Olimpíadas
6
Fux decidiu sobre discurso contra Bolsonaro após conversa com Moraes
7
Comissão especial da Câmara rejeita PEC do Voto Impresso
8
Com Selic a 5,25%, quanto rende investir R$ 1.000 em poupança, Tesouro ou fundo
9
Exército sinaliza ao governo que não apoiará rupturas
10
Taxa de embarque de contêineres da China aos EUA supera US$ 20 mil, novo recorde
darkoz
darkoz 
Joined: Dec 22, 2009
  • Threads: 261
  • Posts: 8725
Thanks for this post from:
Mission146
August 5th, 2021 at 9:18:52 PM permalink
Quote: billryan

In India we're all the rave
Discovered that it's great as aftershave, oh-ho
Dropped in the sea just off Japan
Swapped twenty bottles for an aqua-walkman, oh
Immunity from ridicule
Improves your brains if you're a fool, oh-ho
And I read in the Middle East
Traded some for a hostage release
Now if you're bald it'll give you hair
If you've got straight trousers it'll give you flares
Feeling up you'll get depressed
Out of style here's a brand new dress, oh
It was really vile weather
When we got tarred and feathered
You could hear the six-guns sound
As they chased us out of town



Wow,

So you have given up arguing and.are just posting unrelated song lyrics or Robert Frost poems or whatever that is.

I guess you realize you were not correct about Cytodyn
For Whom the bus tolls; The bus tolls for thee
billryan
billryan
Joined: Nov 2, 2009
  • Threads: 192
  • Posts: 11746
Thanks for this post from:
Mission146
August 5th, 2021 at 10:58:53 PM permalink
Dark Oz sys this:

"No, There are some. I don't see any merit in the lawsuits and I suspect they aren't going anywhere.

My point is those law firms are ambulance chasing.

By the time those are settled (years from now) the Leronlimab trials will be over and the stock price will hopefully have soared. Anyone who sold at a loss and is suing is just a bad investor."

When reality shows this:
Current and former CytoDyn Inc. board members and executives reached a proposed settlement Thursday of a lawsuit in Delaware Chancery Court claiming they enriched themselves at the expense of public investors through “unjustified and oversized awards” of stock and options.

The agreement, which requires the approval of Vice Chancellor Paul A. Fioravanti Jr., would rescind about 5.4 million of the 9.3 million shares and options CytoDyn’s leaders gave themselves in December 2019, according to the court filing disclosing the deal.
darkoz
darkoz 
Joined: Dec 22, 2009
  • Threads: 261
  • Posts: 8725
Thanks for this post from:
Mission146
August 5th, 2021 at 11:08:37 PM permalink
Quote: billryan

Dark Oz sys this:

"No, There are some. I don't see any merit in the lawsuits and I suspect they aren't going anywhere.

My point is those law firms are ambulance chasing.

By the time those are settled (years from now) the Leronlimab trials will be over and the stock price will hopefully have soared. Anyone who sold at a loss and is suing is just a bad investor."

When reality shows this:
Current and former CytoDyn Inc. board members and executives reached a proposed settlement Thursday of a lawsuit in Delaware Chancery Court claiming they enriched themselves at the expense of public investors through “unjustified and oversized awards” of stock and options.

The agreement, which requires the approval of Vice Chancellor Paul A. Fioravanti Jr., would rescind about 5.4 million of the 9.3 million shares and options CytoDyn’s leaders gave themselves in December 2019, according to the court filing disclosing the deal.



Are you unable to differentiate between lawsuits by investors (your original statements referred to those) and lawsuit's filed years ago by former employees?
For Whom the bus tolls; The bus tolls for thee
Mission146
Mission146
Joined: May 15, 2012
  • Threads: 132
  • Posts: 14618
August 5th, 2021 at 11:35:37 PM permalink
From the Annual Report:

Quote:


• Our auditors have issued a going concern opinion, and we will not be able to achieve our objectives and will have to cease operations if we cannot find adequate financing.
• We are a clinical stage biotechnology company with a history of significant operating losses; we expect to continue to incur operating losses, and we may never achieve, let alone maintain, profitability.



Nice! Sounds promising.

https://seekingalpha.com/filing/5643361
https://wizardofvegas.com/forum/off-topic/gripes/11182-pet-peeves/120/#post815219
Mission146
Mission146
Joined: May 15, 2012
  • Threads: 132
  • Posts: 14618
August 5th, 2021 at 11:39:36 PM permalink
And:

Quote:

Our auditors issued an opinion, which includes a going concern exception, in connection with the audit of our annual financial statements for the fiscal year ended May 31, 2021. A going concern exception to an audit opinion means that there is substantial doubt that we can continue as an ongoing business for the next 12 months. If we are unable to continue as a going concern, we might have to liquidate our assets and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial statements. In addition, the inclusion of an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern and our lack of cash resources may materially adversely affect our share price and our ability to raise new capital or to enter into critical contractual relations with third parties. There is no assurance that we will be able to adequately fund our operations in the future.



Same source.
https://wizardofvegas.com/forum/off-topic/gripes/11182-pet-peeves/120/#post815219
billryan
billryan
Joined: Nov 2, 2009
  • Threads: 192
  • Posts: 11746
Thanks for this post from:
Mission146
August 5th, 2021 at 11:54:56 PM permalink
Quote: darkoz

Are you unable to differentiate between lawsuits by investors (your original statements referred to those) and lawsuit's filed years ago by former employees?




The lawsuit in question was filed in April or May of 2020. What month was it you proclaimed this was the cure for covid?
billryan
billryan
Joined: Nov 2, 2009
  • Threads: 192
  • Posts: 11746
Thanks for this post from:
Mission146
August 5th, 2021 at 11:56:28 PM permalink
Quote: Mission146

From the Annual Report:



Nice! Sounds promising.

https://seekingalpha.com/filing/5643361





Haterz
billryan
billryan
Joined: Nov 2, 2009
  • Threads: 192
  • Posts: 11746
Thanks for this post from:
Mission146
August 5th, 2021 at 11:56:48 PM permalink
Quote: Mission146

And:



Same source.



More haterz
Mission146
Mission146
Joined: May 15, 2012
  • Threads: 132
  • Posts: 14618
August 6th, 2021 at 3:36:58 AM permalink
It’s probably true of most penny stocks, but Biotech penny stocks are like walking into a room with 200 blindfolded guys throwing darts at boards and trying to bet on which one will hit a bullseye first.
https://wizardofvegas.com/forum/off-topic/gripes/11182-pet-peeves/120/#post815219

  • Jump to: